If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Trading Update

7 Jul 2005 07:01

Torex Retail PLC07 July 2005 7 July 2005 Torex Retail Plc Trading Update Torex Retail Plc ("Torex Retail" or "the Group"), is pleased to announce apositive update on trading for the six months ended 30 June 2005. This reflects a strong organic performance in all areas of the Group, includingnew LUCAS contract wins totalling approximately £10 million. LUCAS • New sales success for LUCAS, the Group's market leading JAVA based electronic point of sale (EPOS) solution, with a number of significant contract wins with major international retailers including Deichmann, Reiss and Esprit and UK based retailers including RD Scott, Co-op Home Stores and Mitsukoshi. In addition, LUCAS has now been installed in over 40 stores and more than 150 lanes in the UK and Ireland, with more planned for the next few months. These installations will now act as excellent reference sites for our large prospect pipeline. PERFORMANCE MANAGEMENT PRODUCTS • Significant new wins for SMARTDECISION, the Group's merchandise planning product, including Ann Taylor in America, Modelo Continente in Portugal (part of the €1.6 billion turnover Sonnae Group) and Littlewoods and Oldrids in the UK. PETROLEUM & CONVENIENCE • A new £3.3 million contract for the Petroleum and Conveniencedivision, to install its market leading PoS solution 'Iridium' and backoffice system 'Prism' into 225 stores across the UK. BUSINESS DEVELOPMENT Alphameric Retail, which was acquired in November 2004, is now fully integratedinto Torex Retail, ahead of schedule. Through RSS, which was acquired in May 2005, we are achieving real momentum andare already making strong progress in gaining greater penetration of the USmarket, the largest market in the world for retail systems. In addition, we are currently working towards finalising the recommended offersfor XN Checkout Holdings plc and Anker plc. Both of these businesses meet withour strategic goal of ultimately becoming a global market leader and inparticular are expected to be earnings enhancing. This statement regardingearnings enhancement does not constitute a profit forecast nor should it beinterpreted to mean that earnings per share of Torex Retail for the current orfuture years will necessarily match or exceed the historical published earningsper share of Torex Retail. INTERIM RESULTS The Board intends to announce results for the six months ended 30 June 2005 inlate September and expects these results to be consistent with full yearmanagement expectations. The Group continues to enjoy a high level of revenuevisibility, based on strong recurring revenues from its blue-chip customer base.This, coupled with its new business pipeline, gives the directors confidenceabout the Group's prospects for 2005 and beyond. Chris Moore, Chief Executive, Torex Retail Plc, comments: "I am delighted with the progress we have made in all areas of our operationsduring the first half of this year. The cyclical upturn in the market is nowgathering momentum, most notably evidenced by our significant new contract winsfor LUCAS. Coupled with this, our accelerated growth plan through acquisitionsis already positioning us such that we are currently in discussions with some ofthe world's largest retailers as potential customers, both in Europe and theUSA. Enquiries: Torex Retail Plc 0870 050 9900 Chris Moore, Chief Executive Richard Thompson, Group Finance Director Citigate Dewe Rogerson 020 7638 9571 Ginny Pulbrook / Seb Hoyle This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Jul 20113:52 pmRNSIssue of Share Options
5th Jul 20111:30 pmRNSIssue of Equity
22nd Jun 20118:35 amRNSReceives EUR280,000 Grant Funding
13th Jun 20117:00 amRNSDirectorate Appointment
3rd Jun 201110:02 amRNSAGM Statement
11th May 20117:00 amRNSPositive Results in Clinical Evaluation of dCELL
4th May 20117:00 amRNSFinal Results
21st Apr 20117:00 amRNSTissue Regenix enters commercialisation agreement
29th Mar 20117:00 amRNSDirectorate Change
10th Mar 20117:00 amRNSNotice of allowance of patent received
4th Jan 201111:27 amRNSHolding(s) in Company
30th Dec 20109:05 amRNSHolding(s) in Company
23rd Dec 201012:44 pmRNSChange of Adviser
21st Dec 201010:12 amRNSAdviser - Change of Name
16th Dec 20107:00 amRNSResearch Update
10th Dec 20109:20 amRNSChange of Adviser
26th Nov 20103:12 pmRNSChange of Registered Office
23rd Nov 20105:18 pmRNSIssue of Equity
20th Oct 20107:00 amRNSHalf Yearly Report
18th Aug 20102:19 pmRNSHolding(s) in Company
10th Aug 20107:00 amRNSCE Mark Grant
5th Aug 20103:43 pmRNSPatents approved
1st Jul 201010:38 amRNSHolding(s) in Company
29th Jun 20104:37 pmRNSIssue of Equity
29th Jun 20108:06 amRNSFirst day dealings in Tissue Regenix
29th Jun 20107:00 amRNSFirst Day of Dealings
28th Jun 20102:20 pmRNSResult of General Meeting
10th Jun 20103:39 pmRNSSch 1 - Oxeco (to be renamed Tissue Regenix Group)
3rd Jun 20107:00 amRNSAcquisition
21st Apr 201011:20 amRNSResult of AGM
26th Mar 20107:00 amRNSFinal Results
11th Jan 20105:05 pmRNSHolding(s) in Company
23rd Dec 20091:49 pmRNSHolding(s) in Company
23rd Dec 200912:07 pmRNSHolding(s) in Company
22nd Dec 20094:33 pmRNSHolding(s) in Company
17th Dec 20093:50 pmRNSHolding(s) in Company
17th Dec 20092:47 pmRNSHolding(s) in Company
9th Dec 20099:28 amRNSInvesting Policy
23rd Oct 20097:00 amRNSInterim financial report
25th Aug 20092:30 pmRNSHolding(s) in Company
23rd Jul 20097:00 amRNSClosure of subsidiary business
2nd Jun 200912:00 pmRNSAppointment of Non-Executive Director
26th May 20093:00 pmRNSChange of Nominated Adviser Name
20th Apr 20097:00 amRNSFinal Results
24th Mar 200910:18 amRNSAppointment of Broker
18th Mar 200911:54 amRNSStrategic Review and Directorate Change
19th Nov 20087:00 amRNSDirectorate Change
16th Oct 20087:00 amRNSInterim Results
9th Jul 200812:39 pmRNSHolding(s) in Company
29th May 200812:10 pmRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.